Summary
CVS Health Corporation filed an 8-K on December 8, 2021, to announce an update provided at its 2021 Investor Day on December 9, 2021. The company issued a press release that detailed its strategic priorities and provided updated financial projections for the full year 2021, along with initial guidance for 2022. This filing serves to furnish this important forward-looking information to investors.
Key Highlights
- 1CVS Health held its 2021 Investor Day on December 9, 2021.
- 2The company issued a press release at the event, furnished as an exhibit.
- 3The press release discussed CVS Health's strategic priorities.
- 4Updated full-year 2021 financial projections were provided.
- 5Initial financial projections for the fiscal year 2022 were also shared.
- 6This 8-K filing primarily serves to disclose this information under Regulation FD.
Frequently Asked Questions
The main purpose of this 8-K filing is to disclose important forward-looking information shared by CVS Health at its 2021 Investor Day, including updated financial projections and initial guidance for the upcoming year, in compliance with Regulation FD.
CVS Health provided updated full-year 2021 financial projections and initial financial projections for the fiscal year 2022 during its Investor Day event.
The detailed information regarding CVS Health's strategic priorities and financial projections is contained within the press release issued on December 9, 2021, which is furnished as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing does not contain audited financial statements. It is primarily a disclosure of information presented at an Investor Day event, including financial projections, not a filing of historical financial results.